References
- Mateo G, Castellanos M, Rasillo A, Gutierrez N C, Montalban M A, Martin M L, et al. Genetic abnormalities and patterns of antigenic expression in multiple myeloma. Clin Cancer Res 2005; 11: 3661–3667
- Lin P, Owens R, Tricot G, Wilson C S. Flow cytometric immunophenotypic analysis of 306 cases of multiple myeloma. Am J Clin Pathol 2004; 121: 482–488
- Schmidt B, Kremer M, Götze K, John K, Peschel C, Höfler H, Fend F. Bone marrow involvement in follicular lymphoma: comparison of histology and flow cytometry as staging procedures. Leuk Lymphoma 2006; 47: 1857–1862
- Campbell J K, Matthews J P, Seymour J F, Wolf M M, Juneja S K, Australasian Leukaemia Lymphoma Group. Optimum trephine length in the assessment of bone marrow involvement in patients with diffuse large cell lymphoma. Ann Oncol 2003; 14: 273–276
- Nadav L, Katz B Z, Baron S, Yossipov L, Polliack A, Deutsch V, et al. Diverse niches within multiple myeloma bone marrow aspirates affect plasma cell enumeration. Br J Haematol 2006; 133: 530–532
- Kopp H G, Avecilla S T, Hooper A T, Rafii S. The bone marrow vascular niche: home of HSC differentiation and mobilization. Physiology 2005; 20: 349–356
- Kaplan R N, Riba R D, Zacharoulis S, Bramley A H, Vincent L, Costa C, et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 2005; 438: 820–827
- Bishop P W, McNally K, Harris M. Audit of bone marrow trephines. J Clin Path 1992; 45: 1105–1108